Gong HY - Search Results

1

[Current status of 18F-FDG PET in predicting outcome of cancer therapy].

Gong HY, Yu JM. Gong HY, et al. Zhonghua Zhong Liu Za Zhi. 2004 Oct;26(10):577-80. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 16429617 Review. Chinese. No abstract available.

2

[Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].

Gong HY, Yu JM, Fu Z, Li BS, Li JB, Liu TH. Gong HY, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):54-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737623 Chinese.

3

[The state of the art in 4-dimensional radiotherapy].

Gong HY, Yu JM, Wang RB. Gong HY, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jul;29(7):481-3. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18069624 Review. Chinese. No abstract available.

4

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases.

Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, Zhang Z, Liu X. Huang W, et al. Radiother Oncol. 2010 May;95(2):229-33. doi: 10.1016/j.radonc.2010.01.006. Epub 2010 Feb 25. Radiother Oncol. 2010. PMID: 20189259

5

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume delineation of regional lymph node in patients with gastric carcinoma.

Yi Y, Yu J, Li B, Yang F, Huang W, Sun H, Gong H, Zhou T, Lin H. Yi Y, et al. Radiother Oncol. 2010 Aug;96(2):223-30. doi: 10.1016/j.radonc.2010.04.031. Epub 2010 Jun 30. Radiother Oncol. 2010. PMID: 20584555

6

Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.

Huang W, Zhou T, Ma L, Sun H, Gong H, Wang J, Yu J, Li B. Huang W, et al. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1628-35. doi: 10.1007/s00259-011-1838-5. Epub 2011 May 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 21617977 Clinical Trial.

7

Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Huang W, Fan M, Liu B, Fu Z, Zhou T, Zhang Z, Gong H, Li B. Huang W, et al. J Nucl Med. 2014 Oct;55(10):1584-90. doi: 10.2967/jnumed.114.142919. Epub 2014 Sep 11. J Nucl Med. 2014. PMID: 25214640 Free article.

8

[Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma].

Huang W, Li BS, Gong HY, Fan M, Sun HF, Zhou T, Liu XB. Huang W, et al. Among authors: gong hy. Zhonghua Zhong Liu Za Zhi. 2010 Mar;32(3):225-8. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20450594 Chinese.

9

Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer.

Li BS, Gong HY, Huang W, Yi Y, Yu JM, Wang ZT, Zhang ZC, Sun HF, Li HS, Wang LY. Li BS, et al. Among authors: gong hy. Am J Clin Oncol. 2012 Apr;35(2):115-9. doi: 10.1097/COC.0b013e318209ab93. Am J Clin Oncol. 2012. PMID: 21555933 Clinical Trial.

10

Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.

Zhao Q, Wang Z, Huang W, Wang Q, Yu S, Zhou T, Han D, Wu Z, Gong H, Sun H, Zhang J, Wei Y, Li H, Zhang Z, Lin H, Li B. Zhao Q, et al. Oncotarget. 2016 Feb 16;7(7):8422-31. doi: 10.18632/oncotarget.6871. Oncotarget. 2016. PMID: 26761213 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page